This position is a unique role among biotechnology companies as it more closely resembles a buy-side investor role, rather than a conventional business development position in a biopharmaceutical company. In this role, you will be responsible for building the scientific/clinical rationale and investment case for novel drug development ideas and drug acquisition targets. Because it involves the sourcing, assessment, and in-licensing of new assets and new company creation, this position is essential to achieving Roivant’s growth targets and company mission.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Education Level
Bachelor's degree
Number of Employees
251-500 employees